IT1271593B - Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120. - Google Patents
Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.Info
- Publication number
- IT1271593B IT1271593B ITVR940096A ITVR940096A IT1271593B IT 1271593 B IT1271593 B IT 1271593B IT VR940096 A ITVR940096 A IT VR940096A IT VR940096 A ITVR940096 A IT VR940096A IT 1271593 B IT1271593 B IT 1271593B
- Authority
- IT
- Italy
- Prior art keywords
- antibodies
- protein
- pathogenic factors
- hiv virus
- specific
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITVR940096A IT1271593B (it) | 1994-11-30 | 1994-11-30 | Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120. |
JP08518558A JP2000516193A (ja) | 1994-11-30 | 1995-11-30 | エイズ(aids)の治療において選択された病原性因子類を特異的に免疫吸着するためのモジュール |
DE69531069T DE69531069T2 (de) | 1994-11-30 | 1995-11-30 | Verfahren zur spezifischen immunabsorption von selektierten pathogenen faktoren zur behandlung von aids |
AU41864/96A AU4186496A (en) | 1994-11-30 | 1995-11-30 | Method for the specific immunoadsorption of selected pathogenic factors |
PCT/IT1995/000206 WO1996016666A1 (en) | 1994-11-30 | 1995-11-30 | Method for the specific immunoadsorption of selected pathogenic factors |
AT95940399T ATE242637T1 (de) | 1994-11-30 | 1995-11-30 | Verfahren zur spezifischen immunabsorption von selektierten pathogenen faktoren zur behandlung von aids |
EP95940399A EP0954325B1 (en) | 1994-11-30 | 1995-11-30 | Method for the specific immunoadsorption of selected pathogenic factors in the treatment of aids |
ES95940399T ES2201125T3 (es) | 1994-11-30 | 1995-11-30 | Metodo para inmunoadsorcion especifica de factores patogenos seleccionados para el tratamiento del sida. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITVR940096A IT1271593B (it) | 1994-11-30 | 1994-11-30 | Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITVR940096A0 ITVR940096A0 (it) | 1994-11-30 |
ITVR940096A1 ITVR940096A1 (it) | 1996-05-30 |
IT1271593B true IT1271593B (it) | 1997-06-04 |
Family
ID=11427924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITVR940096A IT1271593B (it) | 1994-11-30 | 1994-11-30 | Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0954325B1 (it) |
JP (1) | JP2000516193A (it) |
AT (1) | ATE242637T1 (it) |
AU (1) | AU4186496A (it) |
DE (1) | DE69531069T2 (it) |
ES (1) | ES2201125T3 (it) |
IT (1) | IT1271593B (it) |
WO (1) | WO1996016666A1 (it) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0912188B1 (de) * | 1996-07-12 | 2003-01-29 | Imtec Immundiagnostika Gmbh | Selektives adsorbens zur bindung von retroviren |
US6379708B1 (en) * | 1999-11-20 | 2002-04-30 | Cytologic, Llc | Method for enhancing immune responses in mammals |
MX2007003522A (es) | 2004-09-24 | 2007-06-11 | Beth Israel Hospital | Complicaciones del embarazo. |
US20060153835A1 (en) * | 2005-01-12 | 2006-07-13 | Smith Henry J | Treatment of pre-eclampsia in pregnant women using targeted apheresis |
US20090286271A1 (en) * | 2006-05-31 | 2009-11-19 | Karumanchi Ananth S | Methods of Diagnosing and Treating Complications of Pregnancy |
US9241977B2 (en) | 2013-03-01 | 2016-01-26 | Arthrex, Inc. | Enhanced anabolic cytokine production and delivery system |
DE102016106510A1 (de) * | 2016-04-08 | 2017-10-12 | ToposNomos Ltd. | Verfahren und Vorrichtung zum extrakorporalen Entfernen von pathogenen und/oder überzähligen Bestandteilen aus einer Zellprobe eines Patienten |
CN106267414B (zh) * | 2016-07-01 | 2019-02-19 | 翁炳焕 | 艾滋病免疫净化器 |
CN106267416B (zh) * | 2016-07-01 | 2019-02-19 | 翁炳焕 | 艾滋病治疗仪 |
FR3109734A1 (fr) | 2020-05-04 | 2021-11-05 | Mexbrain | Système de dialyse pour le traitement du sepsis |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1536425A (en) * | 1976-01-30 | 1978-12-20 | Nat Res Dev | Blood treatment |
JPH0218858B2 (it) * | 1979-06-11 | 1990-04-26 | Gambro Lundia Ab | |
JPS57103649A (en) * | 1980-12-18 | 1982-06-28 | Asahi Chemical Ind | Sterilized gamma-globulin fixing column |
EP0103184B1 (en) * | 1982-08-12 | 1990-01-17 | Kanegafuchi Chemical Industry Co., Ltd. | Activation of biocompatible terpolymers with biologicals whose binding complements are pathological effectors |
US5037649A (en) * | 1985-01-11 | 1991-08-06 | Imre Corporation | Method for treatment of HIV-infected patients |
DE3854857T2 (de) * | 1987-06-10 | 1996-08-22 | The Immune Response Corp. Inc., La Jolla, Calif. | Verhütung und behandlung einer retrovirenkrankheit |
US4831118A (en) * | 1987-08-07 | 1989-05-16 | Scripps Clinic And Research Foundation | Flouroplastic immunoaffinity columns for purification of blood proteins |
CZ289006B6 (cs) * | 1990-11-08 | 2001-10-17 | Chiron Corporation | Asialoglykoprotein hepatitis C viru, farmaceutická kompozice s jeho obsahem a jeho pouľití |
US5223397A (en) * | 1991-06-05 | 1993-06-29 | Sangstat Medical Corporation | Soluble hla cross-match |
DE4331358A1 (de) * | 1992-10-12 | 1994-04-14 | Braun Melsungen Ag | Verfahren zur quantitativen selektiven Entfernung oder präparativen Gewinnung von Tumor-Nekrose-Faktor (TNF) oder/und Lipopolysacchariden (LPS) aus wäßrigen Flüssigkeiten |
JP3331398B2 (ja) * | 1993-05-28 | 2002-10-07 | バクスター、インターナショナル、インコーポレイテッド | 不均質な細胞混合物から特定の細胞集団を分離するための方法、装置およびシステム |
-
1994
- 1994-11-30 IT ITVR940096A patent/IT1271593B/it active IP Right Grant
-
1995
- 1995-11-30 EP EP95940399A patent/EP0954325B1/en not_active Expired - Lifetime
- 1995-11-30 ES ES95940399T patent/ES2201125T3/es not_active Expired - Lifetime
- 1995-11-30 DE DE69531069T patent/DE69531069T2/de not_active Expired - Fee Related
- 1995-11-30 WO PCT/IT1995/000206 patent/WO1996016666A1/en active IP Right Grant
- 1995-11-30 JP JP08518558A patent/JP2000516193A/ja not_active Ceased
- 1995-11-30 AT AT95940399T patent/ATE242637T1/de not_active IP Right Cessation
- 1995-11-30 AU AU41864/96A patent/AU4186496A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1996016666A1 (en) | 1996-06-06 |
DE69531069D1 (de) | 2003-07-17 |
EP0954325B1 (en) | 2003-06-11 |
ES2201125T3 (es) | 2004-03-16 |
JP2000516193A (ja) | 2000-12-05 |
ATE242637T1 (de) | 2003-06-15 |
DE69531069T2 (de) | 2004-05-06 |
EP0954325A1 (en) | 1999-11-10 |
AU4186496A (en) | 1996-06-19 |
ITVR940096A0 (it) | 1994-11-30 |
ITVR940096A1 (it) | 1996-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0308936B1 (en) | Antibody heteroconjugates for the killing of HIV-infected cells | |
Stricker et al. | An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells | |
Robinson Jr et al. | Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro | |
Bettaieb et al. | Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura | |
Takeda et al. | Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R | |
IT1271593B (it) | Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120. | |
DE69126301D1 (de) | Hiv-induzierte synzytien blockierender anti-cd-4-antikörper | |
Cavacini et al. | Binding and neutralization activity of human IgG1 and IgG3 from serum of HIV-infected individuals | |
US5286852A (en) | Antibodies specific towards HIV-1 gp 48 | |
Alsmadi et al. | Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities | |
Pak-Leong | Isolation of specific IgM monoclonal antibodies by affinity chromatography using alkaline buffers | |
Tomiyama et al. | Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum | |
US5658569A (en) | Anti-HIV-1 neutralizing antibodies | |
Lundin et al. | A specific assay measuring binding of 125I-Gp 120 from HIV to T4+/CD4+ cells | |
MATSUSHITA et al. | Selective killing of HIV-infected cells by anti-gp120 immunotoxins | |
Chams et al. | Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients | |
Chen et al. | HIV-1 gp4l Binding to Human Peripheral Blood Mononuclear Cells Occurs Preferentially to B Lymphocytes and Monocytes | |
Lewis et al. | HLA-DR peptide inhibits HIV-induced syncytia | |
Biberfeld et al. | Antibodies to Surface Antigens of Lymphocytes and Lymphoblastoid Cells in Cold‐Agglutinin‐Positive Sera from Patients with Mycoplasma pneutnoniae Infection | |
EP0511300A1 (en) | Monoclonal antibody specific for non-immunodominant epitope of hiv proteins | |
Chen et al. | HIV-1 gp41 enhances major histocompatibility complex class I and ICAM-1 expression on H9 and U937 cells | |
Good et al. | In vitro immunomodulation and in vivo immunotherapy of retrovirus-induced immunosuppression | |
Hattori et al. | Anti-HTLV-III and anti-HTLV-I antibodies and T cell subsets in hemophiliacs living in HTLV-I endemic and nonendemic areas of Japan | |
Miller et al. | CD4-independent inhibition of lymphocyte proliferation mediated by HIV-1 envelope glycoproteins | |
US5529776A (en) | Anti-HIV-1 neutralizing antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19971130 |